European Medicines Agency Grants Orphan Drug Designation to Mitazalimab for Pancreatic Cancer
The European Medicines Agency has granted orphan drug designation to mitazalimab for use in patients with pancreatic cancer.
Source: onclive.com
Optimize 1 Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Optimize 1 Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Optimize 1 Trial Today - Breaking & Trending Today
FDA Grants Orphan Drug Designation to Mitazalimab in Pancreatic Cancer
The FDA has granted an orphan drug designation to mitazalimab for use as a potential therapeutic option in patients with pancreatic cancer.
Source: onclive.com